The drug "Nimesil" is a powderfor the preparation of a suspension for oral (oral) use. Medication refers to the pharmacological group of analgesics, anti-inflammatory, non-steroidal, antiplatelet, antipyretic agents.
The drug "Nimesil" (powder) instruction onapplication recommends with Bekhterev's disease, nonspecific polyarthritis of infectious nature, rheumatism. The medicine is shown for bursitis, tenosynovitis, tendinitis, synovitis, arthrosis, nodal erythema. The drug "Nimesil" (powder) is prescribed and with pain syndrome with algodismenorea, in the post-traumatic period. The medicine is shown at a febrile syndrome on a background of pathologies of infectious-inflammatory nature. The "Nimesil" (powder) agent recommends the use of traumatic inflammations of the musculoskeletal system and soft tissues, myalgia, neuralgia. The drug is prescribed for joint arthritis, as well as for pain in the spine.
The medicine "Nimesil" (powder). Mode of application
The contents of the sachet are dissolved in eighty-one hundredmilliliters of water. The drug "Nimesil" (powder) instruction recommends the appointment of twice a day for one bag. The prepared suspension is not subject to storage.
To adverse manifestations of the drug "Nimesil"(Powder) instructions for use include dizziness, ulceration of the mucous membrane of the digestive tract, headache, gastralgia, diarrhea, vomiting, heartburn. In addition, the drug can cause anaphylactic shock, skin rashes, agranulocytosis, anemia, leukopenia, hematuria, thrombocytopenia. In some cases there is an increase in the duration of bleeding.
Medication "Nimesil" (powder) instruction onapplication does not allow for the appointment of lesions in the digestive tract of the erosive ulcerative nature in the stage of exacerbation, with hypersensitivity, bleeding in the digestive tract, renal or hepatic insufficiency. It is not recommended for children up to the age of twelve who are nursing women.
Similarly to other anti-inflammatory drugs(non-steroidal) agents inhibiting (slowing) the synthesis of prostaglandins, nimesulide (the active component of the drug "Nimesil") adversely affects the course of pregnancy and the development of the embryo. Taking medication can lead to premature closure of the arterial duct, a disorder in the kidney function that can go to kidney failure. In addition, the drug can cause hypertension of the pulmonary artery system, increase the chance of bleeding, reduce contractility (ability to reduce) the uterus, cause peripheral edema. In view of these side effects, the drug is contraindicated during pregnancy.
Caution should be observed when prescribing a "Nimesil" medication to patients with type 2 diabetes mellitus, heart failure, arterial hypertension.
With prolonged use of the drug, it is necessary to exercise systematic control over the activity of the kidneys.
According to the patients, the medicine is being transferredgood enough. As the main advantage of the drug is called its effectiveness in cases where other means are powerless (for painful menstruation, gout and other conditions and pathologies). In some cases, one packet per day is sufficient to reduce the severity of the pain syndrome.
It should be remembered that the drug "Nimesil"is not a universal drug for getting rid of all diseases. Before using it, you should consult a doctor and carefully read the annotation.
